Showing results (1-10 of 101) with videos related to
Sort By:
Pageof 11
Clinical Cardiology|October 9, 2004
Will the potential of peroxisome proliferator-activated receptor agonists be realized in the clinical setting?Florian Blaschke, Dennis Bruemmer, Ronald E LawEndocrinology and Metabolism Clinics of North America|September 9, 2006
Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetesFlorian Blaschke, Evren Caglayan, Willa A HsuehPacing and Clinical Electrophysiology : PACE|November 1, 2015
Near-Fatal ICD Lead Dysfunction with Implications for ICD TestingAlexander Wutzler, Philipp Attanasio, Wilhelm Haverkamp, et al.Current Opinion in Pharmacology|March 23, 2005
Metabolic syndrome-interdependence of the cardiovascular and metabolic pathwaysEvren Caglayan, Florian Blaschke, Yasunori Takata, et al.Vascular Pharmacology|June 3, 2006
Vascular effects of TZDs: new implicationsFlorian Blaschke, Robert Spanheimer, Mehmood Khan, et al.Deutsche Medizinische Wochenschrift (1946)|July 13, 2016
[Assessment of risk of sudden cardiac death in patients with hypertrophic cardiomyopathy]Philipp Attanasio, Florian Blaschke, Burkert Pieske, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 22, 2017
Oral administration of a novel lipophilic PPARδ agonist is not neuroprotective after rodent cerebral ischemiaSamuel Knauss, Matthias Endres, Florian Blaschke, et al.Biochemical and Biophysical Research Communications|May 24, 2003
p38 MAP kinase negatively regulates angiotensin II-mediated effects on cell cycle molecules in human coronary smooth muscle cellsUlrich Kintscher, Dennis Bruemmer, Florian Blaschke, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|October 22, 2005
Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetesFlorian Blaschke, Yasunori Takata, Evren Caglayan, et al.Pacing and Clinical Electrophysiology : PACE|May 23, 2013
Electromagnetic interference of avalanche transceivers with cardiac pacemakers and implantable cardioverter defibrillatorsMarc Dorenkamp, Florian Blaschke, Kathleen Voigt, et al.Pageof 11